- Home
- TELO vs PMVP Comparison
TELO vs PMVP Comparison
Compare TELO & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELO
- PMVP
- Stock Information
- Founded
- TELO 2021
- PMVP 2013
- Country
- TELO United States
- PMVP United States
- Employees
- TELO N/A
- PMVP N/A
- Industry
- TELO
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- TELO
- PMVP Health Care
- Exchange
- TELO NYSE
- PMVP Nasdaq
- Market Cap
- TELO 79.2M
- PMVP 71.9M
- IPO Year
- TELO 2024
- PMVP 2020
- Fundamental
- Price
- TELO $2.01
- PMVP $0.95
- Analyst Decision
- TELO
- PMVP Strong Buy
- Analyst Count
- TELO 0
- PMVP 1
- Target Price
- TELO N/A
- PMVP $5.00
- AVG Volume (30 Days)
- TELO 217.3K
- PMVP 281.5K
- Earning Date
- TELO 05-14-2025
- PMVP 05-09-2025
- Dividend Yield
- TELO N/A
- PMVP N/A
- EPS Growth
- TELO N/A
- PMVP N/A
- EPS
- TELO N/A
- PMVP N/A
- Revenue
- TELO N/A
- PMVP N/A
- Revenue This Year
- TELO N/A
- PMVP N/A
- Revenue Next Year
- TELO N/A
- PMVP N/A
- P/E Ratio
- TELO N/A
- PMVP N/A
- Revenue Growth
- TELO N/A
- PMVP N/A
- 52 Week Low
- TELO $1.87
- PMVP $0.81
- 52 Week High
- TELO $8.40
- PMVP $1.83
- Technical
- Relative Strength Index (RSI)
- TELO 37.33
- PMVP 54.98
- Support Level
- TELO $1.88
- PMVP $0.85
- Resistance Level
- TELO $2.19
- PMVP $0.94
- Average True Range (ATR)
- TELO 0.19
- PMVP 0.06
- MACD
- TELO 0.01
- PMVP 0.01
- Stochastic Oscillator
- TELO 19.18
- PMVP 96.22
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.